Melanotan I Protocol: How to Cycle It, Timing & What to Expect

Protocol snapshot

• Typical cycle length: 8 weeks on (4 weeks loading, 4 weeks maintenance), followed by an 8-week off-cycle break; shorter 4 to 6 week pre-event cycles are common
• Frequency: Twice weekly during loading; once or twice weekly during maintenance
• Common delivery routes: Subcutaneous injection
• Key timing notes: UV exposure within 30 to 60 minutes of injection on dosing days; consistent 3 to 4 day spacing between injections

Who This Protocol Is For

Melanotan I attracts people who want a gradual, natural-looking tan rather than the rapid dramatic darkening associated with Melanotan II. Because MT-1 amplifies the skin's response to UV light rather than independently producing pigmentation, the protocol requires actual sun or tanning-bed exposure. That makes it a different kind of commitment than a standalone supplement.

The most common goal is cosmetic pigmentation: building a deeper, more even base tan before a vacation, a summer season, or a competition. A secondary group includes people with fair skin who burn easily and want to build melanin density before extended outdoor time, working with their skin's own UV-response mechanism rather than against it.

Experience with subcutaneous injection matters here. Melanotan I in the user-protocol context is an injectable compound, so comfort with basic peptide administration is a practical prerequisite. People who have run other injectable peptides before find the mechanics familiar. The protocol also rewards patience: MT-1's hallmark is a gradual, natural result. Anyone expecting rapid change tends to push the dose higher than appropriate and runs into avoidable side effects.

How Is a Melanotan I Cycle Structured?

A standard Melanotan I cycle is an eight-week arc that moves through two phases: loading and maintenance. The loading phase builds the foundation; the maintenance phase sustains the result.

During loading, which runs the first four weeks, injections happen twice weekly paired with deliberate UV exposure. The goal is to establish meaningful melanin density before reducing frequency. Clinical data shows melanin density beginning to rise by the end of the first week, with the curve steepening through week two. The maintenance phase covers weeks five through eight, continuing the twice-weekly or reduced once-weekly schedule to hold the pigmentation that has developed.

After the eight-week on-cycle, the standard approach is an eight-week break, which mirrors natural seasonal tanning behavior and gives the body's pigment-turnover process room to operate. Some people run shorter cycles of four to six weeks when timing around a specific trip, and a subset of experienced users settle into a lower-frequency indefinite maintenance approach. Those variations are covered in the Off-Cycle section.

How Your Dose Is Determined

What moves a Melanotan I dose:

• Your goal: The primary divide is between building a base tan from scratch and maintaining an existing one. Front-loading from zero requires more frequent early administration to drive melanin density upward, while maintenance sits at a lower frequency once pigment is established. Users after a light, natural-looking result work toward the lower end of the range; those building deeper pigmentation before an extended outdoor season may lean toward the upper end during loading.
• Experience level: New users and anyone with a history of nausea or peptide sensitivity consistently start at a lower point and titrate upward slowly. Starting above a certain threshold produces substantially higher rates of dose-limiting adverse effects compared to those who titrate carefully, which is why a conservative entry is the standard approach rather than an optional one. Experienced users who know their tolerance often start closer to their established maintenance point.
• Delivery route: Melanotan I in the user-protocol context is administered subcutaneously. The injection route means the administered dose enters circulation relatively quickly, which is why timing before UV exposure matters and why nausea and flushing are tied to dose level rather than to a slower-onset delivery method.
• Individual response: Skin tone and natural melanin baseline vary significantly between people. Someone with a medium natural complexion may reach their desired result well before someone starting from a very fair baseline, and their dose trajectory will differ accordingly.

Melanotan I protocols do not follow a one-size approach. Starting lower and moving upward based on response is the strategy that keeps the protocol functional across a full cycle, rather than forcing a reduction after an overshoot.

Your dose should not be a guess. The MyPeptidePal Protocol Creator takes your skin tone goal, your UV access and exposure plan, and whether you are front-loading or in a maintenance phase and builds your Melanotan I protocol: your dose, your cycle, and your timing.

Get your protocol at mypeptidepal.ai

How Often Do You Take Melanotan I?

The twice-weekly injection frequency that defines the loading phase is not arbitrary. Melanotan I has a relatively short active window once injected, so consistent spacing matters more than precise clock time. A Monday and Thursday pattern, or any split that puts roughly three to four days between injections, keeps melanocortin receptor stimulation relatively even.

Pairing each injection with UV exposure within about 30 to 60 minutes is the key timing principle. MT-1 amplifies the skin's UV response rather than producing pigmentation on its own, so an injection with no UV follow-through adds side effect burden without the tanning stimulus. Most users plan injections specifically for days when sun or a tanning bed is available rather than injecting on a fixed calendar and hoping for sunlight later.

Two timing approaches dominate in practice. The first is a morning injection on UV days, so the active window coincides with planned outdoor or tanning-bed time. The second is an evening injection, chosen specifically to sleep through the transient nausea and flushing that commonly appear in the 30 to 60 minutes after dosing. Both work within the same frequency structure; the choice comes down to which side effect management approach fits the person.

During the maintenance phase, frequency commonly drops to once or twice weekly, with the injection still timed around UV exposure. Less frequent dosing in maintenance is appropriate because melanin density is already established; injections sustain it rather than build it.

Loading and Maintenance Phases

The loading phase of a Melanotan I protocol accomplishes something specific: it drives melanin density upward before the maintenance phase holds it in place. Think of it like priming a surface before painting; without a proper base, the result is thinner and less even.

What distinguishes MT-1's loading phase from some other peptide compounds is that the dose does not change between loading and maintenance. The phase shift is about frequency, not amount, with maintenance pulling back to once or twice weekly as covered in the timing section above. The peptide amount per injection stays consistent across both phases, which simplifies tracking and removes the risk of an accidental dose jump at the transition point.

The loading phase typically runs four weeks, which lines up with clinical data showing melanin density rising through the first two weeks and stabilizing as a foundation by weeks three and four. Injecting more frequently than the protocol calls for does not produce faster results in proportion to the added frequency; it primarily increases side effect burden. The melanin-building process has its own pace, and the loading phase is designed to work with it.

The maintenance phase picks up at week five and runs through week eight. The aim is to sustain what was built, with enough UV activity to keep the skin's pigment response active. Users who find nausea or flushing persistent through loading often find the transition to maintenance frequency a significant relief, since the reduction in injection frequency directly reduces total side effect exposure.

Off-Cycle Considerations

One of the practical differences between Melanotan I and Melanotan II is that the off-cycle structure for MT-1 is less rigid. MT-2 protocols carry explicit recommendations for a defined break after the on-cycle to manage melanocortin receptor desensitization. For MT-1, the primary strategy to prevent over-saturation is titrating down to a lower maintenance frequency rather than complete cessation.

The standard pattern is an eight-week break after an eight-week on-cycle. The rationale is partly receptor management and partly natural pigment turnover: after a full cycle, melanin levels are elevated, and the off period allows gradual fading rather than an abrupt stop that leaves pigmentation looking patchy when the next cycle begins. Most users report visible color for four to six weeks after stopping, which is why many plan cycles to peak before a summer season and allow natural fade afterward.

A subset of experienced users skip the hard off period and settle into a very low frequency maintenance approach that sustains a large proportion of peak pigmentation indefinitely. This option appears in community data, though long-term clinical data on continuous use is limited. For new users, the standard eight-on, eight-off pattern is the established starting point. The break gives both the body and the user a natural reset, makes it easier to assess retained pigmentation from the cycle, and keeps the system responsive for the next one.

Melanotan I is not FDA-approved for cosmetic tanning use in the United States, and regulatory agencies in multiple countries including Australia and Ireland have issued consumer warnings against unregulated melanotan products.

What to Expect Week by Week

• Week 1 to 2: The first week is mostly groundwork with few visible changes. Transient nausea and mild flushing commonly appear within minutes of injection and resolve within 30 to 60 minutes; these are the clearest early signs the compound is active. Some users notice a subtle color shift on sun-exposed areas like the face and arms by the end of week one. Clinical data shows melanin density beginning to rise by day seven.
• Week 3 to 4: Color becomes apparent to others. Skin tone deepens and evens out, particularly on areas receiving UV exposure. Many users describe UV sessions during this phase as producing results that exceed what the same exposure would deliver without MT-1. Clinical data places the melanin density peak around day fifteen.
• Week 5 to 8: Frequency drops to maintenance levels and achieved color stabilizes. Nausea and flushing typically become less prominent as injection frequency decreases. Users with naturally medium complexions often find this phase produces their best-looking result: an even tone that sits in what is commonly described as a natural Mediterranean range.
• Beyond 8 weeks: Pigmentation generally holds for four to six weeks after the last injection before gradual fading begins. Many people plan their cycle to peak before the most UV-active months and allow the color to diminish naturally over autumn.

A well-run cycle, paced through the loading phase with consistent UV pairing, commonly produces a gradual, even deepening of skin tone that looks natural rather than sudden. Individual results vary by baseline skin tone, UV consistency, dose, and adherence, so these timelines are patterns, not guarantees.

Common Protocol Mistakes

Starting too high, too fast. Research consistently shows that starting above a certain threshold produces substantially higher rates of adverse effects compared to a titrated approach, and rapid escalation dramatically increases the rate of people who discontinue entirely. The mistake is almost always impatience. Starting at the lower end of the range and increasing gradually is not a cautious option; it is the strategy that keeps the protocol functional.

Injecting without UV follow-through. MT-1 amplifies the UV response; it does not generate pigmentation independently. Users who inject on days they do not get sun or tanning-bed exposure are adding side effect burden without the tanning stimulus that makes the protocol work. Injections should be paired with UV on the same day, within the activation window.

Expecting Melanotan II speed from Melanotan I. The two compounds produce different results on different timelines. MT-1's gradual, natural-looking result is the reason many people choose it specifically, but some users come in expecting rapid dramatic change and misread the early weeks as the protocol not working. The melanin curve rises over two to four weeks; patience through loading is part of the protocol, not a sign something is wrong.

Poor storage and handling. Reconstituted Melanotan I is sensitive to both temperature and light. Keeping the mixed peptide above the recommended refrigeration threshold for more than a few hours reduces potency measurably, and exposing it to UV light during preparation degrades activity within minutes. The practical result of improper storage is unintentional under-dosing: the person believes they are taking their planned amount but is receiving significantly less, which stalls results and makes troubleshooting harder.

Continuing loading-level frequency past the cycle window. Running high-frequency dosing past the standard on-cycle period is not the same as the intentional low-frequency maintenance approach seen in community data. Continuous high-frequency dosing increases cumulative side effect burden and moves toward receptor over-stimulation rather than stable maintenance. The seasonal pattern exists because it works.

Sourcing from unverifiable suppliers. Melanotan I purchased from unregulated sources lacks independent quality verification, consistent purity, and proper chain of custody. The practical risks include unknown impurities, inconsistent concentration, and no assurance the product was handled correctly during storage or shipping. The quality argument is about manufacturing standards, independent testing, and traceability.

Frequently Asked Questions

How long is a typical Melanotan I cycle?

The most commonly run cycle spans eight weeks: four weeks of loading phase followed by four weeks of maintenance, then an eight-week off period. Shorter four to six week cycles are used when timing for a specific event or vacation. The exact length that fits a particular goal and baseline is personalized in the MyPeptidePal Protocol Creator.

How often do you take Melanotan I?

During the loading phase, twice weekly is the standard frequency, with injections spaced three to four days apart to keep stimulation consistent. The maintenance phase commonly drops to once or twice weekly. Injections are ideally timed to pair with UV exposure on the same day, within about 30 to 60 minutes of administering.

Does Melanotan I need a loading phase?

Yes. The loading phase is what drives melanin density upward before the maintenance phase holds it in place. Skipping directly to a lower maintenance frequency without the loading foundation produces a thinner, less even result. The difference between loading and maintenance is injection frequency, not dose amount; the peptide amount per injection stays consistent across both phases.

Do you need to cycle off Melanotan I?

The standard approach includes an eight-week break after an eight-week cycle, allowing for natural pigment turnover and preventing over-stimulation. The off-cycle structure for MT-1 is less rigid than for MT-2; experienced users sometimes move to a very low frequency maintenance approach rather than stopping entirely, though long-term clinical data on that approach is limited.

Does Melanotan I work without sun exposure?

No. MT-1 amplifies the skin's UV response rather than generating pigmentation independently. Without UV exposure the compound will not produce a tan. Injections should be paired with planned sun or tanning-bed exposure on the same day to activate the pigment response.

How long does the tan last after stopping Melanotan I?

Most users report visible color for approximately four to six weeks after the last injection, after which gradual fading occurs. This natural fade timeline is why many people plan their cycle to peak before their most UV-active period and allow the color to diminish naturally rather than stopping abruptly mid-season.

Disclaimer

This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.

Sources

The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and documented real-world protocols for Melanotan I in one place.